Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026

Go back to Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Asianada, Inc. (NASDAQ: ASND) Delayed: 242.09 +3.19 (1.34%)
Previous Close $238.90    52 Week High $21.79 
Open $239.38    52 Week Low $11.92 
Day High $242.73    P/E N/A 
Day Low $236.87    EPS $-0.07 
Volume 215,058